dual glp-1/glucagon receptor agonists LY3437943, a novel triple glucagon, GIP, and GLP-1 agonist for glycemic control and weight loss: From discovery to clinical proof of concept: Cell Metabolism Survodutide Dual GLP-1/Glucagon Receptor Agonist
Description
Learn why Jardiance and metformin are used together, how to take these medications, and side effects they may cause.
GLP-1 medications have benefits and risks for fertility patients
To help people figure out who qualifies, whats involved and what to expect for first-time GLP-1 users, a pair of weight management specialists at MUSC Health sat down for this Q&A.
Glucose-dependent insulinotropic polypeptide (GIP) is secreted by enteroendocrine K cells, primarily located in the upper small intestine, in response to food intake and plays a significant role in the postprandial regulation of nutrient metabolism
In this issue of Diabetologia, Maida et al
Early tight control reduces long-term vascular risk
